Daniel Crocker
Internal Medicine · Rocky Mount, NCNPI 1700886272
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 118 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Novo Nordisk at 24.6% of the total. Reporting peaked in 2019 at $1,390 and has fallen 98.9% since, to $15 in 2022.
Across 118 payments — averaging $13.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$390
- AstraZeneca$260
- GSK$182
- Amgen$158
- Johnson & Johnson$119
- Takeda Pharmaceuticals U.S.A., Inc.$107
- plus $372 from 15 others
What the payments were for
- Food & beverage$1,587100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 42 | $390 |
| AstraZeneca(2 entities) | 14 | $260 |
| GSK | 7 | $182 |
| Amgen | 12 | $158 |
| Johnson & Johnson | 9 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $107 |
| Scilex Pharmaceuticals Inc. | 6 | $79 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $62 |
| Pfizer | 4 | $50 |
| Amarin Pharma, Inc. | 2 | $27 |
| Novartis | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Grifols USA, LLC | 1 | $17 |
| Avanir Pharmaceuticals, Inc. | 1 | $15 |
| AbbVie | 1 | $15 |
| Vifor Pharma, Inc. | 1 | $13 |
| Shionogi Inc | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Hikma Pharmaceuticals USA | 1 | $12 |
| Merck | 1 | $11 |
| Astellas Pharma US Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$111
How this compares
$1,587 in reported general payments places this provider in the 80th percentile of 3,302 internal medicine providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 25 | $344 |
| Gabapentin | 11 | $295 |
| Levothyroxine Sodium | 14 | $186 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Rocky Mount
- Nirmish ShahDurham$862K
- Eugene WrightFayetteville$839K
- Saad UsmaniCharlotte$551K
- Bhakti PaulRaleigh$536K
- Mary KlotmanDurham$478K
- Manesh PatelDurham$435K
- Millie LongChapel Hill$374K
- Marc JohnsonCharlotte$342K
- Christina CraterRaleigh$330K
- Jamy ArdWinston Salem$293K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.